JAMA Oncology - NCCN authors receive $$$ from drug industry

[Gfunk6]

Hot off the presses from JAMA Oncology (http://oncology.jamanetwork.com/article.aspx?articleid=2546172):

Of 125 guideline authors, 108 (86%) had at least 1 reported FCOI. Authors received an average of $10 011 (range, $0-$106 859) in general payments (GPs), which include consulting, meals, lodging, and similar transfers of value, and $236 066 (range $0-$2 756 713) in industry research payments (RPs), including funding associated with clinical trials. Approximately 84% of authors received GPs, while 47% received RPs. Eight (6%) had FCOIs in excess of the $50 000 net and/or $20 000 single-company maximums stipulated by NCCN.

Where there is smoke, there is fire . . .

---

Members don't see this ad.

 

[medicinewoman101]

haha cant be surprised about this; how else does surgery for high risk prostate or for surgery for multiply node positive head and neck oropharynx possibly end up as treatment recommendations.

 

[medgator]

Most of the $$$ was RP, research payments.

Can't say I'm shocked, and while not ideal, it's going to happen if you have academicians writing the guidelines